Clinical trial: Percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma - A long-term follow-up study

Alimentary Pharmacology and Therapeutics

Volumn 28, Issue 3, 2008, Pages 304-311

  Tsai, W L ^a,b   Cheng, J S ^a,b,c   Lai, K H ^a,b   Lin, C P ^d   Lo, G H ^a,b   Hsu, P I ^a,b   Yu, H C ^a,b   Lin, C K ^a,b   Chan, H H ^a,b   Chen, W C ^a,b   Chen, T A ^a,b   Li, W L ^a   Liang, H L ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Yongkang Veterans Hospital   (Taiwan)

^d God's Help Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALCOHOL; ALPHA FETOPROTEIN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CANCER SIZE; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; FEVER; FOLLOW UP; HEMATURIA; HUMAN; INJECTION; KAPLAN MEIER METHOD; LENGTH OF STAY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NAUSEA AND VOMITING; OVERALL SURVIVAL; PERCUTANEOUS ACETIC ACID INJECTION; PERCUTANEOUS ETHANOL INJECTION; PRIORITY JOURNAL; RECURRENCE RISK; STATISTICAL ANALYSIS; TUMOR NECROSIS; TUMOR RECURRENCE;

ACETIC ACID; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; ETHANOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; LIVER NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SURVIVAL ANALYSIS; TIME FACTORS; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 64649090705     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03702.x     Document Type: Article

References (31)

1. Kao JH, Chen DS. Changing disease burden of hepatocellular carcinoma in the FarEast and Southeast Asia. Liver Int 2005; 25: 696-703.
2. Llovet JM, Schwartz M. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25: 181-200.
3. Bruix J, Sherman M, Llovet M, et al. EASL panel of experts on HCC: clinical management of hepatocellualr carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-30.
4. Beaugrand M, N'Kontchou G, Seror O, Ganne N, Trinchet JC. Local/Regional and systemic treatments of hepatocellu- lar carcinoma. Semin Liver Dis 2005; 25: 201-11.
5. Hou TI, Huang YS, Wu JC. Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future per-spectives. J Chin Med Assoc 2005; 68: 155-9.
6. Omata M, Tateishi R, Yoshida H, Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004; 127 (Suppl 1): S159-67.
7. Huang GT, Lee PH, Tsang YM, et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 2005; 242: 36-42.
8. Yamamoto J, Okada S, Shimada K, et al. Treatment strategy for small hepatocel- lular carcinoma: comparison of long- term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001; 34: 707-13.
9. Lencioni RA, Allgaier HP, Olschwski M, etal. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-40.
10. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma <4 cm. Gastroenterology 2004; 127: 1714-23.
11. Shiina S, Teratani T, Obi S, etal. A randomized controlled trial of radiofre-quency ablation with ethanol injection for small hepatocellular carcinoma. Gastrotenterology 2005; 129: 122-30.
12. Livraghi T, Solbiati L, Melonji MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radiofrequency ablation: complications encountered in a multi- center study. Radiology 2003; 226: 441-51.
13. Mulier S, Mulier P, Ni Y, etal. Complications of radiofrequency coagulation of liver tumors. Br J Surg 2002; 89: 1206-22.
14. Stasi MD, Buscarini L, Livraghi T, etal. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma: a multicenter survey of evaluation practices and complication rates. ScandJ Gastroenterol 1997; 32: 1168-73.
15. Hou TI, Lee SD, Wu JC. Ethanol injection versus radiofrequency ablation for hepatocellular carcinoma: which is better. Gastroenterology 2005; 128: 806-7.
16. Ebara M, Okabe S, Kita K, et al. Percutaneous ethanol injection for small hepatocellular carcinoma. J Hepatol 2005; 43: 458-64.
17. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 961-7.
18. Lencioni R, Llovet JM. Percutaneous ethanol injection for hepatocellular carcinoma: alive or dead? J Hepatol 2005; 43: 377-80.
19. Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing pecutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998; 27: 67-72.
20. Hou TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Comparison of precutaneous acetic acid injection and percutaneous theanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study. Scand J Gastroenterol 2003; 38: 770-8.
21. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomized controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous thanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54: 1151-6.
22. Ohnishi K, Ohyama N, Ito S, Fujiwara K. Ultrasound guided intratumor injection of acetidc acid for the treatment of small hepatocellular carcinoma. Radiology 1994; 193: 747-52.
23. Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M. Percutaneous ethanol injection therapy for liver tumors. Eur J Ultrasound 2001; 13: 95-106.
24. Lin XD, Lin LW. Local injection therapy for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2006; 5: 16-21. 25 Lencioni R, Crocetti L. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma.Clin Liver Dis 2005; 9: 301-14.
25. Llovet JM, Vilana R, Bru C, et al.Increased risk of tumor seeding after percutaneous radiofrequency for single epatocellular carcinoma. Hepatology 2001; 33: 1124-9.
26. Kurkohchi K, Watanabe S, Masaki T, et al. Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinoma difficult to treat. Int J Oncol 2002; 21: 611-5.
27. Timpl R, Wiedemann H, Delden VV, Furthmayr H, Kuhn K. A network model for the organization of type IV collagen molecules in basement membranes. EurJ Biochem 1981; 120: 203-11.
28. Sala M, Llovet JM, Vilana R, et al. Initialresponse to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004; 40: 1352-60.
29. Koda M, Murawaki Y, Mitsuda A, et al. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 2000; 88: 529-37. 31 Castells A, Bruix J, Bru C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993; 18: 1121-6.
30. Daniele B, De Sio I, Izzo F, et al. CLIP Investigators. Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: Cancer of the Liver Italian Program (CLIP 08) retrospective case-control study. J Clin Gastroenterol 2003; 36: 63-7.
31. Liang WL, Yang CF, Pan HB, et al. Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection treatment. Radiology 2000; 214: 769-74.